SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

269 hedge funds and large institutions have $4.2B invested in Sarepta Therapeutics in 2018 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 76 increasing their positions, 110 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
269
Holders Change
+15
Holders Change %
+5.91%
% of All Funds
6.17%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
53
Increased
76
Reduced
110
Closed
35
Calls
$198M
Puts
$111M
Net Calls
+$86.7M
Net Calls Change
+$48.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$113M
3
RI
RTW Investments
New York
+$51M
4
Ameriprise
Ameriprise
Minnesota
+$38.2M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$34.1M

Top Sellers

1
HM
HealthCor Management
New York
-$72.9M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$64.5M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$64.3M
4
EA
Emerald Advisers
Pennsylvania
-$35.8M
5
Millennium Management
Millennium Management
New York
-$33.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
301
Tower Research Capital (TRC)
New York
– -$3K -61 Closed
MAM
302
Meeder Asset Management
Ohio
– -$2K -30 Closed
FAM
303
Formidable Asset Management
Ohio
– -$2K -7 Closed
9 10 11 12
13